Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO03075) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Daptomycin
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug Marketed but Withdrawn from Market
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=16129688"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| NADPH-dependent oxidoreductase (nfrA) | DME Info | Staphylococcus aureus | [1] | |||
| References | ||||||
| 1 | Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection. Peptides. 2013 Feb;40:77-81. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.